Age group |
Group I
(suture) (n=44) |
Group II
(fibrin glue) (n=43) |
P value |
||
Male |
Female |
Male |
Female |
||
21 – 30 |
5 (21.7%) |
4 (19%) |
4 (20%) |
6 (26%) |
0.318 |
31 – 40 |
8 (34.7%) |
6 (28.5%) |
6 (30%) |
7 (30.4%) |
0.621 |
41 – 50 |
9 (39.1%) |
10 (47.6%) |
9 (45%) |
8 (34.7%) |
0.581 |
51 – 60 |
1 (4.3%) |
1 (4.7%) |
1 (5%) |
2 (8.6%) |
0.319 |
Total |
23 (100%) |
21 (100%) |
20 (100%) |
23 (100%) |
|
Mean ± SD |
44.5±6.4 |
42.6±6.8 |
41.4±5.2 |
43.5±5.8 |
0.486* |
Grading |
Group I
(suture) (n=44) |
Group II
(fibrin glue) (n=43) |
P value |
I |
4 (9%) |
6 (13.9%) |
0.618 |
II |
24 (54.5%) |
20 (46.5%) |
|
III |
16 (36.3%) |
17 (39.5%) |
|
Total |
44 (100%) |
43 (100%) |
Duration
of surgery in minutes |
Group I
(suture) (n=44) Mean ± SD |
Group II
(fibrin glue) (n=43) Mean ± SD |
P value |
Mean |
20.67 ± 4.89 |
12.22 ± 3.12 |
<.0001 |
Min |
10 |
8 |
|
Max |
30 |
19 |
Outcome
measure |
Group I
(suture) (n=44) |
Group II
(fibrin glue) (n=43) |
P value |
||||||
15th
day (mean rank) |
30th
day (mean
rank) |
90th
day (mean
rank) |
180th
day (mean
rank) |
15th
day (mean rank) |
30th
day (mean
rank) |
90th
day (mean
rank) |
180th
day (mean
rank) |
|
|
Graft
inflammation |
31.54 |
28.2 |
24.89 |
No inflammation reported |
18.41 |
21 |
24 |
No inflammation reported |
<.0001 |
Graft
stability |
24.13 |
22.5 |
23.5 |
24 |
26.67 |
27.04 |
25.28 |
24.89 |
<.001 |
Patients
discomfort |
30.80 |
27.26 |
25.28 |
No discomfort |
19.28 |
22.23 |
23.5 |
No discomfort |
<.001 |
Complication |
Group I
(suture) (n=44) |
Group II
(fibrin glue) (n=43) |
P value |
Donor
site granuloma |
5 (11.3%) |
0 |
<.001 |
Pyogenic
granuloma |
0 |
3 (6.9%) |
<.01 |
Suture
granuloma |
8 (18.1%) |
0 |
<.001 |
Reverse
graft |
0 |
2 (4.6%) |
0.071 |
Sub-conjuctival
hemorrhage |
1 (2.2%) |
2 (4.6%) |
0.362 |
Recurrence |
3 (6.8%) |
0 |
<.001 |